Key result
Adding a 23-protein score to conventional risk factors improves MI discrimination across Chinese and European cohorts.
Why the study?
Advances in proteomics assays enable measurement of thousands of plasma proteins, which could facilitate machine learning-based approaches to enhance risk prediction of myocardial infarction.
Does adding a 23-protein machine learning-based proteomics score to conventional risk factors and polygenic scores improve the risk prediction of myocardial infarction in Chinese and European adults?
Cohort (n=41,187)
Yes
Does adding a 23-protein machine learning-based proteomics score to conventional risk factors and polygenic scores improve the risk prediction of myocardial infarction in Chinese and European adults?
A machine learning-derived 23-protein biomarker score significantly enhances 10-year myocardial infarction risk prediction beyond conventional risk factors and polygenic risk scores in both Chinese and European populations.
Answers are grounded in this paper and cite their sources.
Protein score may refine MI reclassification in Chinese adults; leaves open prospective validation before clinical use.
BACKGROUND: Advances in proteomics assays enable measurement of thousands of plasma proteins, which could facilitate machine learning-based approaches to enhance risk prediction of disease. METHODS: We measured plasma levels of >9500 proteins among 4000 Chinese adults (1937 myocardial infarction [MI] cases and 2026 subcohort), using both Olink Explore (2923 proteins) and SomaScan (6597 proteins) platforms. Protein-based risk prediction models were constructed, using conventional and machine learning approaches, with model performance assessed via discrimination (C-statistic), classification (net reclassification index; NRI) and calibration. Protein scores were compared and combined with conventional risk factors and polygenic scores (PGS), and externally validated in 37,187 Europeans (630 MI cases) in UK Biobank. FINDINGS: Overall, 451 Olink and 530 SomaScan proteins were significantly associated (5% false discovery rate) with MI risk after adjustment for conventional risk factors. The protein prediction models based on Olink, SomaScan, or both platforms combined, outperformed conventional risk factors and PGS using discrimination, classification and calibration. The protein score using 23 Boruta-selected (Olink/SomaScan: 11/12) proteins yielded a 3.3-fold difference in 10-year cumulative incidence of MI between the top and bottom 20% risk groups (3.6 [95%CI: 3.1-4.1] vs 1.1 [0.9-1.2] per 100), compared with 2.5-fold (2.5 [2.2-2.9] vs 1.0 [0.9-1.2]) and 1.5-fold (1.9 [1.6-2.1] vs 1.3 [1.1-1.4]) differences for conventional and PGS, respectively. Adding this protein score to conventional risk factors increased C-statistics from 0.846 (0.829-0.862) to 0.864 (0.849-0.879), yielding an NRI of 72%. External validation in 37,187 participants in UK Biobank by adding 23 Boruta-selected proteins to conventional risk factors yielded comparable improvement in C-statistics for MI (from 0.710 [0.688-0.731] to 0.733 [0.710-0.756]) and 45% improvement in NRI (NRI 45%). CONCLUSIONS: Machine learning identified subsets of proteins for improved MI risk prediction beyond conventional risk factors and PGS, showing the potential for developing small panel proteomics assays to improve disease risk prediction.
No takes yet. Share an insight, caveat, or question.
Wright et al. (2026) conducted a cohort in Myocardial infarction (n=41,187). 23-protein machine learning-based risk score (Olink and SomaScan) vs. Conventional risk factors and polygenic scores (PGS) was evaluated on 10-year cumulative incidence and risk prediction (C-statistic and net reclassification index) of myocardial infarction (C-statistic 0.864, 95% CI 0.849-0.879). Adding a 23-protein score to conventional risk factors improved MI discrimination in Chinese and European adults.
Synapse has enriched 10 related papers. Consider them for comparative context: